Insider Transactions in Q3 2021 at Biora Therapeutics, Inc. (BIOR)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 15
2021
|
Matthew T Cooper General Manager, Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
560
-0.44%
|
$560
$1.66 P/Share
|
|
Aug 15
2021
|
Eric D Esparbes Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,718
-2.83%
|
$5,718
$1.66 P/Share
|
|
Aug 15
2021
|
Hutan Hashemi Chief Compliance Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
158
-0.7%
|
$158
$1.66 P/Share
|
|
Aug 15
2021
|
Harry Stylli Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,335
-0.07%
|
$10,335
$1.66 P/Share
|
|
Aug 15
2021
|
Damon Silvestry Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,478
-0.51%
|
$1,478
$1.66 P/Share
|
|
Aug 15
2021
|
Clarke Neumann |
SELL
Payment of exercise price or tax liability
|
Direct |
2,336
-1.71%
|
$2,336
$1.66 P/Share
|
|
Aug 06
2021
|
Troy Seelye Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
23,673
-28.38%
|
$23,673
$1.94 P/Share
|
|
Jul 01
2021
|
Surbhi Sarna Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,137
+50.0%
|
-
|